TCM

TCG Crossover Management Portfolio holdings

AUM $876M
1-Year Est. Return 23.66%
This Quarter Est. Return
1 Year Est. Return
+23.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$214M
AUM Growth
–
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
15
New
Increased
Reduced
Closed

Top Buys

1
+$29.1M
2
+$26M
3
+$23.6M
4
CBAY
Cymabay Therapeutics
CBAY
+$20M
5
ALPN
Alpine Immune Sciences Inc
ALPN
+$16.2M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$29.1M 13.63%
+1,741,228
2
$26M 12.16%
+1,314,000
3
$23.6M 11.05%
+2,750,037
4
$20M 9.35%
+5,905,400
5
$16.2M 7.59%
+1,170,212
6
$15.7M 7.37%
+1,082,213
7
$14.4M 6.74%
+882,353
8
$12M 5.6%
+850,450
9
$11.4M 5.32%
+663,694
10
$10.1M 4.71%
+24,381
11
$9.84M 4.61%
+138,889
12
$8.88M 4.16%
+1,045,215
13
$7.16M 3.35%
+225,000
14
$5.97M 2.8%
+95,000
15
$3.34M 1.56%
+555,000